These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 3455614

  • 1. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
    Atkins RM, Yates AJ, Gray RE, Urwin GH, Hamdy NA, Beneton MN, Rosini S, Kanis JA.
    J Bone Miner Res; 1987 Aug; 2(4):273-9. PubMed ID: 3455614
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effects of intravenous alendronate in Paget's disease of bone.
    O'Doherty DP, McCloskey EV, Vasikaran S, Khan S, Kanis JA.
    J Bone Miner Res; 1995 Jul; 10(7):1094-100. PubMed ID: 7484285
    [Abstract] [Full Text] [Related]

  • 5. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP, Gertz BJ, Tindale W, Sciberras DG, Survill TT, Kanis JA.
    J Bone Miner Res; 1992 Jan; 7(1):81-7. PubMed ID: 1549961
    [Abstract] [Full Text] [Related]

  • 6. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K, Merry P, Scott DG.
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [Abstract] [Full Text] [Related]

  • 7. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J.
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [Abstract] [Full Text] [Related]

  • 8. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Harinck HI, Bijvoet OL, Blanksma HJ, Dahlinghaus-Nienhuys PJ.
    Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
    [Abstract] [Full Text] [Related]

  • 9. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
    Arboleya L, Sánchez J, Iglesias G, Arranz JL.
    Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
    [Abstract] [Full Text] [Related]

  • 10. Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease.
    Vega E, Gonzalez D, Ghiringhelli G, Mautalen C.
    J Bone Miner Res; 1987 Aug; 2(4):267-71. PubMed ID: 3455613
    [Abstract] [Full Text] [Related]

  • 11. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR.
    J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
    McCloskey EV, Yates AJ, Beneton MN, Galloway J, Harris S, Kanis JA.
    Bone; 1987 Jan; 8 Suppl 1():S35-41. PubMed ID: 2825741
    [Abstract] [Full Text] [Related]

  • 13. Determinants of remission of Paget's disease of bone.
    Patel S, Stone MD, Coupland C, Hosking DJ.
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [Abstract] [Full Text] [Related]

  • 14. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 15. Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
    Thiébaud D, Jaeger P, Burckhardt P.
    J Bone Miner Res; 1987 Feb; 2(1):45-52. PubMed ID: 3455156
    [Abstract] [Full Text] [Related]

  • 16. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
    Yates AJ, Percival RC, Gray RE, Atkins RM, Urwin GH, Hamdy NA, Preston CJ, Beneton MN, Russell RG, Kanis JA.
    Lancet; 1985 Jun 29; 1(8444):1474-7. PubMed ID: 2861411
    [Abstract] [Full Text] [Related]

  • 17. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
    Gray RE, Yates AJ, Preston CJ, Smith R, Russell RG, Kanis JA.
    Q J Med; 1987 Sep 29; 64(245):755-67. PubMed ID: 2966965
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD, Hawthorne AB, Kerr D, Webster G, Hosking DJ.
    J Bone Miner Res; 1990 Dec 29; 5(12):1231-5. PubMed ID: 2075835
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone.
    Reginster JY, Treves R, Renier JC, Amor B, Sany J, Ethgen D, Picot C, Franchimont P.
    J Bone Miner Res; 1994 May 29; 9(5):615-9. PubMed ID: 8053389
    [Abstract] [Full Text] [Related]

  • 20. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
    Price RI, Gutteridge DH, Stuckey BG, Kent GN, Retallack RW, Prince RL, Bhagat CI, Johnston CA, Nicholson GC, Stewart GO.
    J Bone Miner Res; 1993 Feb 29; 8(2):209-17. PubMed ID: 8442439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.